Breast cancer treatment with a group of drugs called Poly (ADP-ribose) polymerase (PARP) inhibitors exhibited promising results; they can be used alone or in combination with other chemotherapeutic agents or radiotherapy4. Here, PARP1 is linked to breast carcinoma.